Changjiang Runfa Health Industry Co., Ltd.

Equities

002435

CNE100000QC7

Heavy Electrical Equipment

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
2.73 CNY 0.00% Intraday chart for Changjiang Runfa Health Industry Co., Ltd. +4.60% -34.53%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Changjiang Runfa Health Industry Co., Ltd. Approves Board Elections CI
Changjiang Runfa Health Unit's Antibacterial Drug Passes Drug Regulator's Consistency Evaluation MT
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Changjiang Runfa Health Industry Co., Ltd.(XSEC:002435) added to S&P Global BMI Index CI
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Yongxing Custom Value No. 1 Private Equity Securities Investment Fund managed by Hunan Yongxing Private Equity Fund Management Co., Ltd. completed the acquisition of 5% stake in Changjiang Runfa Health Industry Co., Ltd. from Changjiang Runfa Group Co., Ltd. CI
Rongtong No. 5 Securities Investment Fund, managed by Ningbo Ningju Asset Management Center (Limited Partnership) agreed to acquire a 5.99% stake in Changjiang Runfa Health Industry Co., Ltd. from Changjiang Runfa Group Co., Ltd. CI
Yongxing Custom Value No. 1 Private Equity Securities Investment Fund managed by Hunan Yongxing Private Equity Fund Management Co., Ltd. agreed to acquire 5% stake in Changjiang Runfa Health Industry Co., Ltd. from Changjiang Runfa Group Co., Ltd. for approximately CNY310 million. CI
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Changjiang Runfa Health Boosts Stake in Jianghe Pharmaceutical to 87% MT
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Changjiang Runfa Health Buys 58% of Peer for 39 Million Yuan; Shares Rally 10% MT
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Changjiang Runfa Health's Shareholder and Parties Acting in Concert Plan to Cut Stakes CI
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Changjiang Runfa Health Industry Co., Ltd. Announces Final Cash Dividend Plan to Be Implemented on A Shares for 2020, Payable on June 18, 2021 CI
Changjiang Runfa Health Industry Co., Ltd. Approves Cash Dividend for the Year 2020 CI
Changjiang Runfa Health Industry Co., Ltd. Proposes Final Cash Dividend for the Year 2020 CI
Changjiang Runfa Health Industry Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Changjiang Runfa Health Industry Co., Ltd. Announces Board Appointments CI
Suzhou Sushang Health Industry Investment Partnership Enterprise (Limited Partnership) completed the acquisition of 9.67% stake in Changjiang Runfa Health Industry Co., Ltd. from Beijing Yangshu Venture Capital Center (Limited Partnership) managed by Yangshu Growth Investment Co., Ltd. and Yangshu Hengkang Zhangjiagang Bonded Area Pharmaceutical Industry Equity Investment Enterprise (LP). CI
Chart Changjiang Runfa Health Industry Co., Ltd.
More charts
ChangjiangRunfa Health Industry Co., Ltd., formerly ChangjiangRunfa Medicine Co., Ltd., is a China-based company mainly engaged in the production and sale of pharmaceutical raw materials and preparations. The Company is principally engaged in research and development, production and sales of pharmaceutical raw materials and preparations, proprietary Chinese medicines and providing medical services, medical investment and investment in health industry businesses. The Company is also engaged in the research, development, manufacture, sale and service of elevator guide rail system components. The Company’s products include solid guide rails, rough guide rails, hollow guide rails, accessories and automotive sections, channel steel products, as well as escalator guide rails and others. The Company offers its elevator guide rail products for elevator manufacturers, including Mitsubishi, Otis, KONE and Thyssen. The Company distributes its products in domestic markets and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. 002435 Stock
  4. News Changjiang Runfa Health Industry Co., Ltd.
  5. Changjiang Runfa Health Buys 58% of Peer for 39 Million Yuan; Shares Rally 10%